What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Internal medicine
His main research concerns Immunology, Transplantation, Immune system, Graft-versus-host disease and Cancer research.
His research on Immunology frequently connects to adjacent areas such as Receptor.
His Transplantation research incorporates elements of Disease, Cytokine, Antigen presentation and MHC class II.
His Immune system research includes elements of Prostate, Stem cell, Antigen and Transcription factor.
His study in Graft-versus-host disease is interdisciplinary in nature, drawing from both Proinflammatory cytokine, Adoptive cell transfer and Ruxolitinib.
Robert Zeiser has included themes like Tumor microenvironment, Leukemia and Oncogene Addiction, Oncogene in his Cancer research study.
His most cited work include:
- Origin, fate and dynamics of macrophages at central nervous system interfaces (468 citations)
- Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. (410 citations)
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy (328 citations)
What are the main themes of his work throughout his whole career to date?
Robert Zeiser mostly deals with Immunology, Transplantation, Cancer research, Graft-versus-host disease and Internal medicine.
As part of his studies on Immunology, he frequently links adjacent subjects like Stem cell.
The various areas that Robert Zeiser examines in his Transplantation study include CD8, Disease, Bone marrow and Immunotherapy.
His work carried out in the field of Cancer research brings together such families of science as Receptor, Inflammasome, Leukemia and Haematopoiesis.
Robert Zeiser has researched Graft-versus-host disease in several fields, including Proinflammatory cytokine, Innate immune system, Major histocompatibility complex and Myeloperoxidase.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.
He most often published in these fields:
- Immunology (50.00%)
- Transplantation (39.24%)
- Cancer research (35.13%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (35.13%)
- Internal medicine (23.42%)
- Transplantation (39.24%)
In recent papers he was focusing on the following fields of study:
Cancer research, Internal medicine, Transplantation, Graft-versus-host disease and Oncology are his primary areas of study.
When carried out as part of a general Cancer research research project, his work on Myeloid is frequently linked to work in Chemistry, therefore connecting diverse disciplines of study.
His work deals with themes such as Observational study, Nursing, Homologous chromosome and Immune system, which intersect with Transplantation.
To a larger extent, Robert Zeiser studies Immunology with the aim of understanding Immune system.
His Graft-versus-host disease study combines topics in areas such as Proinflammatory cytokine, Cytotoxic T cell and Antigen.
His Oncology study integrates concerns from other disciplines, such as Melphalan, Liver disease, Toxicity, ThioTEPA and Carmustine.
Between 2019 and 2021, his most popular works were:
- Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease (74 citations)
- Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN) (48 citations)
- Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation (46 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Internal medicine
Robert Zeiser mainly investigates Cancer research, Transplantation, Chemistry, Graft-versus-host disease and Inflammation.
His Cancer research study combines topics from a wide range of disciplines, such as Inflammasome, KRAS and Leukemia.
His Transplantation study incorporates themes from Clinical trial, Disease, Ruxolitinib, Azithromycin and Glucocorticoid.
His Graft-versus-host disease research integrates issues from Tumor necrosis factor alpha, Neurotoxicity, Downregulation and upregulation, Microglia and CD80.
His studies in Inflammation integrate themes in fields like Acquired immune system, Immune system, Carcinogenesis, Cancer and Crosstalk.
His Immune system research is included under the broader classification of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
